Pharmacologic Inhibition of Ezrin-Radixin-Moesin Phosphorylation is a Novel Therapeutic Strategy in Rhabdomyosarcoma

por Proudfit, Austin, Bhunia, Nabanita, Pore, Debasis, Parker, Yvonne, Lindner, Daniel, Gupta, Neetu
Publicado 2020

CBL0137 increases the targeting efficacy of Rovalpituzumab tesirine against tumour-initiating cells in small cell lung cancer

por Lindner, Daniel J., Wildey, Gary, Parker, Yvonne, Dowlati, Afshin, Stark, George R., De, Sarmishtha
Publicado 2020

RNase L is a negative regulator of cell migration

por Banerjee, Shuvojit, Li, Geqiang, Li, Yize, Gaughan, Christina, Baskar, Danika, Parker, Yvonne, Lindner, Daniel J., Weiss, Susan R., Silverman, Robert H.
Publicado 2015

PBRM1 loss in kidney cancer unbalances the proximal tubule master transcription factor hub to repress proximal tubule differentiation

por Gu, Xiaorong, Enane, Francis, Tohme, Rita, Schuerger, Caroline, Radivoyevitch, Tomas, Parker, Yvonne, Zuberi, Eric, Przychodzen, Bartlomiej, Jha, Babal Kant, Lindner, Daniel, Rini, Brian, Saunthararajah, Yogen
Publicado 2021

MEK inhibition abrogates sunitinib resistance in a renal cell carcinoma patient-derived xenograft model

por Diaz-Montero, C Marcela, Mao, Frances J, Barnard, John, Parker, Yvonne, Zamanian-Daryoush, Maryam, Pink, John J, Finke, James H, Rini, Brian I, Lindner, Daniel J
Publicado 2016

Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblasts

por Visconte, Valeria, Tabarroki, Ali, Zhang, Li, Parker, Yvonne, Hasrouni, Edy, Mahfouz, Reda, Isono, Kyoichi, Koseki, Haruhiko, Sekeres, Mikkael A, Saunthararajah, Yogen, Barnard, John, Lindner, Daniel, Rogers, Heesun J, Tiu, Ramon V
Publicado 2014

Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia

por Guan, Yihong, Hasipek, Metis, Jiang, Dongxu, Tiwari, Anand D., Grabowski, Dale R., Pagliuca, Simona, Kongkiatkamon, Sunisa, Patel, Bhumika, Singh, Salendra, Parker, Yvonne, LaFramboise, Thomas, Lindner, Daniel, Sekeres, Mikkael A., Mian, Omar Y., Saunthararajah, Yogen, Maciejewski, Jaroslaw P., Jha, Babal K.
Publicado 2022

KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer

por Qiu, Hong, Makarov, Vladimir, Bolzenius, Jennifer K., Halstead, Angela, Parker, Yvonne, Wang, Allen, Iyer, Gopakumar V., Wise, Hannah, Kim, Daniel, Thayaparan, Varna, Lindner, Daniel J., Haber, Georges-Pascal, Ting, Angela H., Ren, Bing, Chan, Timothy A., Arora, Vivek, Solit, David B., Lee, Byron H.
Publicado 2023

Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma

por Hasipek, Metis, Grabowski, Dale, Guan, Yihong, Alugubelli, Raghunandan Reddy, Tiwari, Anand D., Gu, Xiaorong, DeAvila, Gabriel A., Silva, Ariosto S., Meads, Mark B., Parker, Yvonne, Lindner, Daniel J., Saunthararajah, Yogen, Shain, Kenneth H., Maciejewski, Jaroslaw P., Reu, Frederic J., Phillips, James G., Jha, Babal K.
Publicado 2021

CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors

por Saygin, Caner, Wiechert, Andrew, Rao, Vinay S., Alluri, Ravi, Connor, Elizabeth, Thiagarajan, Praveena S., Hale, James S., Li, Yan, Chumakova, Anastasia, Jarrar, Awad, Parker, Yvonne, Lindner, Daniel J., Nagaraj, Anil Belur, Kim, J. Julie, DiFeo, Analisa, Abdul-Karim, Fadi W., Michener, Chad, Rose, Peter G., DeBernardo, Robert, Mahdi, Haider, McCrae, Keith R., Lin, Feng, Lathia, Justin D., Reizes, Ofer
Publicado 2017